Evrysdi Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

evrysdi

roche registration gmbh  - risdiplam - spier-atrofie, spinale - andere geneesmiddelen voor aandoeningen van het musculo-skeletale systeem - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.

Sunitinib Accord Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische middelen - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Primene 10 % inf. opl. i.v. Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

primene 10 % inf. opl. i.v.

baxter sa-nv - cysteïne 1,89 g/1000 ml; taurine 0,6 g/1000 ml; methionine 2,4 g/1000 ml; valine 7,6 g/1000 ml; tryptofaan 2 g/1000 ml; fenylalanine 4,2 g/1000 ml; threonine 3,7 g/1000 ml; isoleucine 6,7 g/1000 ml; glycine 4 g/1000 ml; leucine 10 g/1000 ml; proline 3 g/1000 ml; lysine 11 g/1000 ml; glutaminezuur 10 g/1000 ml; alanine 8 g/1000 ml; asparaginezuur 6 g/1000 ml; serine 4 g/1000 ml; tyrosine 0,45 g/1000 ml; ornithine hydrochloride 3,18 g/1000 ml; arginine 8,4 g/1000 ml; histidine 3,8 g/1000 ml - oplossing voor infusie - combinations

Primene 10 % inf. opl. i.v. Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

primene 10 % inf. opl. i.v.

baxter sa-nv - cysteïne 1,89 g/1000 ml; taurine 0,6 g/1000 ml; methionine 2,4 g/1000 ml; valine 7,6 g/1000 ml; tryptofaan 2 g/1000 ml; fenylalanine 4,2 g/1000 ml; threonine 3,7 g/1000 ml; isoleucine 6,7 g/1000 ml; glycine 4 g/1000 ml; leucine 10 g/1000 ml; proline 3 g/1000 ml; lysine 11 g/1000 ml; glutaminezuur 10 g/1000 ml; alanine 8 g/1000 ml; asparaginezuur 6 g/1000 ml; serine 4 g/1000 ml; tyrosine 0,45 g/1000 ml; ornithine hydrochloride 3,18 g/1000 ml; arginine 8,4 g/1000 ml; histidine 3,8 g/1000 ml - oplossing voor infusie - combinations

Thalidomide Lipomed Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - thalidomide - multiple myeloma - immunosuppressiva - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Ztalmy Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - andere anti-epileptica - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

Dextroforme 1 mg/ml siroop Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dextroforme 1 mg/ml siroop

conforma sa-nv - dextromethorfanhydrobromide 1 mg/ml - siroop - 1 mg/ml - dextromethorfanhydrobromide 1 mg/ml - dextromethorphan

Aqua Cuprozincica Conforma 7,65 mg/ml - 25,5 mg/ml cut. opl. Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aqua cuprozincica conforma 7,65 mg/ml - 25,5 mg/ml cut. opl.

conforma sa-nv - zinksulfaatheptahydraat - eq. zinksulfaat 25 mg/g; kopersulfaat 7,65 mg/ml - oplossing voor cutaan gebruik - 7,65 mg/ml - 25,5 mg/ml - kopersulfaat 7.65 mg/ml; zinksulfaatheptahydraat - antiseptics and disinfectants

Codeinesiroop met Eucalyptolsmaak Conforma 2,67 mg/ml siroop Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

codeinesiroop met eucalyptolsmaak conforma 2,67 mg/ml siroop

conforma sa-nv - codeïne 2,67 mg/ml - siroop - 2,67 mg/ml - codeïne 2.67 mg/ml - opium alkaloids and derivatives

Codeinesiroop met Eucalyptolsmaak Conforma 2,67 mg/ml siroop Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

codeinesiroop met eucalyptolsmaak conforma 2,67 mg/ml siroop

conforma sa-nv - codeïne 2,67 mg/ml - siroop - 2,67 mg/ml - codeïne 2.67 mg/ml - opium alkaloids and derivatives